Skip to main content
Log in

Prevent postoperative recurrence of paediatric Crohn’s disease by risk-based treatment and early monitoring

  • Adis Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

Abstract

The course of Crohn’s disease (CD) is especially aggressive in paediatric CD, with surgical resection of intestinal macroscopic lesions often being necessary, Unfortunately, surgery is not curative, and most patients experience postoperative disease recurrence within years of undergoing the initial surgery. Paediatric CD patients have a higher lifelong risk of repeated surgical interventions than adults, and preventing disease recurrence is of utmost importance to ensure growth and quality of life. Prevention generally involves prophylactic drugs (e.g. anti-TNFα, thiopurines, metronidazole), as well as early and regular monitoring (with fecal calprotectin levels and ileocolonoscopy), with step-up therapy as needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Vuitton L, Peyrin-Biroulet L. Pharmacological prevention of postoperative recurrence in Crohn’s disease. Drugs. 2020;80(4):385–99.

    Article  CAS  Google Scholar 

  2. Yerushalmy-Feler A, Assa A. Pharmacological prevention and management of postoperative relapse in pediatric Crohn’s disease. Paediatr Drugs. 2019;21(6):451–60.

    Article  Google Scholar 

  3. Splawski JB, Pffefferkorn MD, Schaefer ME, et al. NASPGHAN clinical report on postoperative recurrence in pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2017;65(4):475–86.

    Article  Google Scholar 

  4. Amil-Dias J, Kolacek S, Turner D. Surgical management of Crohn disease in children: guidelines from the paediatric IBD Porto Group of ESPGHAN. J Pediatr Gastroenterol Nutr. 2017;64(5):818–35.

    Article  Google Scholar 

  5. Hammoudi N, Cazals-Hatem D, Auzolle C. Association between microscopic lesions at ileal resection margin and recurrence after surgery in patients with Crohn’s disease. Clin Gastroenterol Hepatol. 2019;18(1):141–9.

    Article  Google Scholar 

  6. Auzolle C, Nancey S, Tran-Minh ML. Male gender, active smoking and previous intestinal resection are risk factors for post-operative endoscopic recurrence in Crohn’s disease: results from a prospective cohort study. Aliment Pharmacol Ther. 2018;48(9):924–32.

    Article  Google Scholar 

  7. Ruemmele FM, Veres G, Kolho KL. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease. J Crohns Colitis. 2014;8:1179–207.

    Article  CAS  Google Scholar 

  8. Orlando A, Mocciaro F, Renna S, et al. Early post-operative endoscopic recurrence in Crohn’s disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort. J Crohns Colitis. 2014;8(10):1217–21.

    Article  Google Scholar 

  9. Hukkinen M, Pakarinen MP, Merras-Salmio L. Fecal calprotectin in the prediction of postoperative recurrence of Crohn’s disease in children and adolescents. J Pediatr Surg. 2016;51(9):1467–72.

    Article  Google Scholar 

  10. Rivière P, Vermeire S, Irles-Depe M. No change in determining Crohn’s disease recurrence or need for endoscopic or surgical intervention with modification of the Rutgeerts’ scoring system. Clin Gastroenterol Hepatol. 2019;17(8):1643–5.

    Article  Google Scholar 

  11. Gjuladin-Hellon T, Gordon M, Iheozor-Ejiofor Z, et al. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn’s disease. Cochrane Database Syst Rev. 2019;6(6):CD008414.

    PubMed  Google Scholar 

  12. Ford AC, Khan KJ, Talley NJ, et al. 5-aminosalicylates prevent relapse of Crohn’s disease after surgically induced remission: systematic review and meta-analysis. Am J Gastroenterol. 2011;106(3):413–20.

    Article  CAS  Google Scholar 

  13. Doherty G, Bennett G, Patil S, et al. Interventions for prevention of post-operative recurrence of Crohn’s disease. Cochrane Database Syst Rev. 2009;7(4):CD006873.

    Google Scholar 

  14. Regueiro M, Schraut W, Baidoo L, et al. Infliximab prevents Crohn’s disease recurrence after ileal resection. Gastroenterology. 2009;136(2):441–50.

    Article  CAS  Google Scholar 

  15. Rutgeerts P, Hiele M, Geboes K. Controlled trial of metronidazole treatment for prevention of Crohn’s recurrence after ileal resection. Gastroenterology. 1995;108(6):1617–21.

    Article  CAS  Google Scholar 

  16. Yamamoto T, Nakahigashi M, Umegae S, et al. Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn’s disease: a prospective, non-randomized, parallel, controlled study. Aliment Pharmacol Ther. 2007;25(1):67–72.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

ESK searched the literature, prepared the bibliography and wrote the first draft. YAH contributed to the preparation, content, writing and revision of the article.

Corresponding author

Correspondence to Young-A. Heo.

Ethics declarations

Funding

The preparation of this review was not supported by any external funding. ESK and YAH are employed by Adis International Ltd./Springer Nature.

Conflict of interest

ESK and YAH declare no relevant conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, E.S., Heo, YA. Prevent postoperative recurrence of paediatric Crohn’s disease by risk-based treatment and early monitoring. Drugs Ther Perspect 36, 377–381 (2020). https://doi.org/10.1007/s40267-020-00758-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40267-020-00758-2

Navigation